Cravath, Swaine & Moore LLP Logo
  • Practices
  • People
  • Careers
  • News & Insights
  • Practices
  • People
  • Careers
  • News & Insights
  • Our Story
  • The Cravath System
  • Diversity & Inclusion
  • Pro Bono
  • Alumni Journal
  • 200.Cravath

Cravath’s London Office Moves to 100 Cheapside

Read More

News & Insights

Johnson & Johnson’s $6.5 Billion Acquisition of Momenta Pharmaceuticals, Inc.

August 19, 2020

On August 19, 2020, Johnson & Johnson announced that it has entered into a definitive agreement to acquire Momenta Pharmaceuticals, Inc. (“Momenta”), a company that discovers and develops novel therapies for immune-mediated diseases, in an all cash transaction for approximately $6.5 billion. The acquisition provides an opportunity for the Janssen Pharmaceutical Companies of Johnson & Johnson to broaden its leadership in immune-mediated diseases and drive further growth through expansion into autoantibody-driven disease. Cravath is representing Johnson & Johnson in connection with the transaction.

The Cravath team is led by partner Robert I. Townsend III and includes associates Jin-Kyu Baek, James Ding, Ty A. Carleton and Jerome C. Newton on M&A matters; partner J. Leonard Teti II and associate Andrew T. Davis on tax matters; partner David J. Kappos, practice area attorney Anthony N. Magistrale and associate Ryan J. Wichtowski on intellectual property matters, partner Jonathan J. Katz and associates Matthew J. Bobby and Dixing Tang on executive compensation and benefits matters; partner Matthew Morreale on environmental matters; and practice area attorney Brian M. Budnick on real estate matters.

Related Practices & Industries

  • Corporate
  • Mergers and Acquisitions
  • Tax
  • Intellectual Property
  • Executive Compensation and Benefits
  • Environmental
  • Healthcare and Life Sciences

People

Photo
Name
Robert I. Townsend III
Title
Corporate
Title
Partner
Email
rtownsend@cravath.com
Phone
+1-212-474-1964
vCard
Download vCard

    Education

    • J.D., 1990, Harvard Law School
      magna cum laude
    • A.B., 1987, Harvard College
      magna cum laude

    Admitted In

    • New York
    Photo
    Name
    J. Leonard Teti II
    Title
    Tax
    Title
    Partner
    Email
    lteti@cravath.com
    Phone
    +1-212-474-1896
    vCard
    Download vCard

      Education

      • J.D., 2005, University of Virginia School of Law
        Order of the Coif
      • A.B., 1999, Princeton University
        with Honors

      Admitted In

      • New York
      Photo
      Name
      Andrew T. Davis
      Title
      Tax
      Title
      Partner
      Email
      adavis@cravath.com
      Phone
      +1-212-474-1272
      vCard
      Download vCard

        Education

        • LL.M., 2020, New York University School of Law
        • J.D., 2014, Stanford Law School
        • A.B., 2010, Princeton University

        Admitted In

        • New York
        Photo
        Name
        David J. Kappos
        Title
        Corporate
        Title
        Partner
        Email
        dkappos@cravath.com
        Phone
        +1-212-474-1168
        vCard
        Download vCard

          Education

          • J.D., 1990, University of California, Berkeley, School of Law
          • B.S., 1983, University of California, Davis
            summa cum laude

          Admitted In

          • New York
          • California
          • District of Columbia
          Photo
          Name
          Jonathan J. Katz
          Title
          Executive Compensation and Benefits
          Title
          Partner
          Email
          jkatz@cravath.com
          Phone
          +1-212-474-1538
          vCard
          Download vCard

            Education

            • LL.M., 2013, New York University School of Law
            • J.D., 2007, Benjamin N. Cardozo School of Law
              Order of the Coif, Dean's Distinguished Scholar, summa cum laude
            • B.S., 2003, Cornell University

            Admitted In

            • New York
            Photo
            Name
            Matthew J. Bobby
            Title
            Executive Compensation and Benefits
            Title
            Partner
            Email
            mbobby@cravath.com
            Phone
            +1-212-474-1128
            vCard
            Download vCard

              Education

              • J.D., 2012, Harvard Law School
                magna cum laude
              • M.A., 2009, University of Pennsylvania
              • B.A., 2009, University of Pennsylvania
                Phi Beta Kappa, summa cum laude

              Admitted In

              • New York
              Photo
              Name
              Matthew Morreale
              Title
              Corporate
              Title
              Partner
              Email
              mmorreale@cravath.com
              Phone
              +1-212-474-1534
              vCard
              Download vCard

                Education

                • J.D., 1997, Columbia Law School
                  Harlan Fiske Stone Scholar
                • M.S., 1994, University of Pennsylvania
                • B.A., 1990, University of Pennsylvania
                • B.A.S., 1990, University of Pennsylvania

                Admitted In

                • New York
                Photo
                Name
                Brian M. Budnick
                Title
                Corporate
                Title
                Practice Area Attorney
                Email
                bbudnick@cravath.com
                Phone
                +1-212-474-1914
                vCard
                Download vCard

                  Education

                  • J.D., 2011, Benjamin N. Cardozo School of Law
                    cum laude
                  • B.A., 2006, University of Virginia

                  Admitted In

                  • New York

                  Related News & Insights

                  Deals & Cases

                  March 12, 2025

                  Johnson & Johnson’s $5 Billion Registered Notes Offering and Concurrent €4 Billion Notes Offering

                  Cravath represented the underwriters in connection with the $5 billion registered notes offering of Johnson & Johnson, the world’s largest, most diversified healthcare products company. Cravath also represented the underwriters in connection with Johnson & Johnson’s concurrent €4 billion notes offering. Proceeds of both offerings will be used to finance the acquisition of Intra‑Cellular Therapies, Inc. by Johnson & Johnson. The transactions closed on February 20, 2025, and February 26, 2025, respectively.

                  Cravath Bicentennial

                  Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.

                  Explore

                  Cravath, Swaine & Moore LLP Logo
                  • CONTACT US
                  • OUR STORY
                  • ALUMNI PORTAL
                  • DISCLAIMERS & NOTICES

                  Attorney Advertising. ©2025 Cravath, Swaine & Moore LLP.